Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fully human anti-C-X-C chemokine receptor 3 (CXCR3) antibodies and methods of use thereof

Fully human anti-C-X-C chemokine receptor 3 (CXCR3) antibodies and methods of use thereof

US Patent 10668148 · Granted Jun 2, 2020

Estimated economic value: $52,324,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fully human antibodies that bind to vascular endothelial growth factor receptor 2024
Antibody therapeutics that bind CD382024
Antigen binding proteins that bind PD-L12024
Antigen binding proteins that bind PD-L12024
Antigen binding proteins that bind PD-L12024
CD-38 directed chimeric antigen receptor constructs2023
Antibody therapeutics that bind CD1232023
Antigen binding proteins that bind WISP12022
Antigen binding proteins that bind PD-12022
Antigen binding proteins that bind PD-12022
CD38 antibody drug conjugate2021
Antibody therapeutics that bind CD1372021